DOTA-[Tyr3]-Octreotide Acid
DOTA-(Tyr3)-octreotate can be obtained through preparation of DOTA-containing peptides and radionucleotide complexes as antitumor agents for treating somatostatin postive tumor and metastasized tumors.
| Catalog Number | R1831 |
| Alternative Name(s) | DOTATATE, DOTA-(Tyr³,Thr⁸)-Octreotide, DOTA-[Tyr3] Octreotide Acid (Octreotate), 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH acetate salt (Disulfide bond) |
| Molecular Formula | C65H90N14O19S2 |
| CAS# | 177943-89-4 |
| Purity | >98% |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/dota-tyr3-octreotide-acid-item-r1831-39362.html |